What finasteride is approved to treat
Finasteride 1 mg is approved for one hair condition: male pattern hair loss in men. The medical name is androgenetic alopecia, the gradual, inherited thinning at the crown, mid-scalp and hairline that is driven by the hormone DHT. Finasteride lowers DHT (see how it works). It is not approved for women or children, and it is not a treatment for other kinds of hair loss, such as patchy loss or shedding after illness, which have different causes.
Who the trials studied
The approval rests on three 12-month, placebo-controlled trials in 1,879 men aged 18 to 41 with mild to moderate, but not complete, hair loss. Two of the trials (1,553 men) enrolled men with thinning mainly at the vertex, or crown. The third (326 men) enrolled men with thinning in the anterior mid-scalp, the area behind the hairline. About 88% of participants were Caucasian.
Two later studies widened the picture:
- Older men: a 24-month trial in 424 men aged 41 to 60 found that finasteride 1 mg improved scalp hair compared with placebo, with improvement evident by 6 months and continuing through 24 months.
- Men over 65: the efficacy trials did not include them, and the label says efficacy in the elderly has not been established.
The label also reports results by ethnic group from the two crown trials. Average hair count rose with finasteride and fell with placebo among Black men (up 49 hairs versus down 27) and Asian men (up 53 versus down 38), although those groups were small (84 and 17 men).
Which areas of the scalp respond
The evidence is strongest for the crown and the mid-scalp, and weakest for the temples. In the crown trials, men on finasteride had 107 more hairs than the placebo group in a 1-inch circle after a year. The mid-scalp trial, published by Leyden and colleagues in 1999, also found a significant increase in hair count and better ratings from patients, investigators and photographs. For the temples, the label is direct: efficacy in bitemporal recession has not been established. Hair counts in the mid-scalp trial did not include the hairline itself.
Finasteride is better at keeping hair than at bringing it back. At five years, 90% of men on finasteride were rated as improved or unchanged on photographs, compared with 25% of men on placebo.
What it can and cannot do
Finasteride slows or stops further loss in most men and regrows some hair in about half, but it does not restore a fully bald scalp. The trials enrolled men who still had hair in the thinning area, and the drug works by rescuing follicles that have shrunk, so starting earlier leaves more to save. Benefit takes at least three months to appear and lasts only while the drug is continued. The results timeline gives the month by month figures, and dosage covers how to take it.
Who should not take it
Women who are or may become pregnant must not take finasteride, and it is not indicated for women or children at all. The other listed contraindication is allergy to any ingredient. The label advises caution in men with liver problems, since the liver breaks the drug down. Men who have regular prostate screening should know that finasteride lowers PSA readings (see interactions and lab tests). Before starting, it is worth reading about side effects.
Common questions
Does finasteride work for a receding hairline?
The label says efficacy in bitemporal recession, meaning the temples, has not been established. The proven benefit is at the crown and mid-scalp.
Does finasteride work after age 40?
Yes, there is trial evidence. A 24-month study of 424 men aged 41 to 60 found improvement over placebo from month 6 onward.
Can finasteride regrow hair on a completely bald area?
The trials enrolled men with mild to moderate loss, not complete loss, so there is no good evidence that it does.
Is finasteride used for other types of hair loss?
Its only approved hair use is male pattern hair loss. Use in women is off-label and covered on the finasteride and women page.
Sources
- Organon. Propecia (finasteride) tablets 1 mg, full prescribing information and patient information. DailyMed, National Library of Medicine. DailyMed: Propecia label
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology, 1998. PubMed 9777765
- Leyden J, Dunlap F, Miller B, et al. Finasteride in the treatment of men with frontal male pattern hair loss. Journal of the American Academy of Dermatology, 1999. PubMed 10365924
- Whiting DA, Olsen EA, Savin R, et al. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss. European Journal of Dermatology, 2003. PubMed 12695131
- Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. European Journal of Dermatology, 2002. PubMed 11809594